Skip to content

The Antiretroviral Pipeline

  • Chad Cipiti

July 2017 By Tim Horn INTRODUCTION The antiretroviral (ARV) pipeline remains robust, with several drugs, coformulations, and biologics currently in Phase II and III stages of development. The trends are clear: maximizing the safety and efficacy of standard three-drug regimens;…

Read more

HIV Cure Research: CROI 2017 Update Webinar

  • Chad Cipiti

On May 3, 2017, Treatment Action Group (TAG) and the DARE Collaboratory Community Advisory Board held a community webinar to provide an update on research results presented at the Conference in Retroviruses and Opportunistic Infections (CROI). The webinar was presented by TAG's Basic…

Read more

HIV, TB, HCV, Global Health and Research Communities Call on Congress to Protect the Fogarty International Center

  • Chad Cipiti

Dear Majority Leader McConnell, Minority Leader Schumer, Speaker Ryan, and Democratic Leader Pelosi: We the undersigned urge Congress to reject devastating funding cuts to the National Institutes of Health (NIH) proposed under the President’s Fiscal Year (FY) 2018 “skinny budget,” released on March 16, 2017. Of grave concern is the targeted elimination of the Fogarty International Center at NIH. This indiscriminate cut jeopardizes life-saving research required to end devastating global diseases like tuberculosis (TB) and HIV/AIDS, as well as malaria, dengue, and Ebola.

Read more
Back To Top